asenapine has been researched along with Anxiety in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Einat, H; Stukalin, Y | 1 |
| Carrilho, CG; Coletti, RF; de Barros, JA; de Souza, TB; Farias, DM; Machado, S; Moreno, SE; Murillo-Rodriguez, E; Oliveira, MS; Veras, AB | 1 |
| Akar, F; Eraldemir, FC; Erden, F; Gumuslu, E; Kokturk, S; Mutlu, O; Tanyeri, P; Tatar, OC; Ulak, G; Yasar, AB | 1 |
| Fernández Monge, M; Lloreda Morillo, MJ; Robles MartÃnez, M | 1 |
| Imanishi, T; Kondo, M; Koyama, T; Ohyama, M; Yamauchi, M | 1 |
| Kane, JM; Mackle, M; Panagides, J; Snow-Adami, L; Szegedi, A; Zhao, J | 1 |
1 trial(s) available for asenapine and Anxiety
| Article | Year |
|---|---|
A randomized placebo-controlled trial of asenapine for the prevention of relapse of schizophrenia after long-term treatment.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Anxiety; Dibenzocycloheptenes; Double-Blind Method; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Secondary Prevention; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Weight Gain; Young Adult | 2011 |
5 other study(ies) available for asenapine and Anxiety
| Article | Year |
|---|---|
Analyzing test batteries in animal models of psychopathology with multivariate analysis of variance (MANOVA): One possible approach to increase external validity.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Antimanic Agents; Anxiety; Behavior Rating Scale; Behavior, Animal; Bipolar Disorder; Dibenzocycloheptenes; Disease Models, Animal; Female; Heterocyclic Compounds, 4 or More Rings; Lithium; Luria-Nebraska Neuropsychological Battery; Male; Mice; Multivariate Analysis; Psychopathology; Reproducibility of Results; Sex Factors | 2019 |
Systemic Administration of Antipsychotic Asenapine Pre or Postnatal does not Induce Anxiety-like Behaviors in Mice.
Topics: Animals; Animals, Suckling; Antipsychotic Agents; Anxiety; Dibenzocycloheptenes; Exploratory Behavior; Female; Heterocyclic Compounds, 4 or More Rings; Male; Maze Learning; Mice; Pregnancy; Prenatal Exposure Delayed Effects | 2018 |
Effects of Asenapine and Paliperidone on Depression, Anxiety and Analgesy in Mice: Alterations in Brain Neurotrophic Factors, Neurogenesis, and Blood Enzyme Levels.
Topics: Animals; Anxiety; Brain; Brain-Derived Neurotrophic Factor; Depression; Dibenzocycloheptenes; Heterocyclic Compounds, 4 or More Rings; Hippocampus; Mice; Neurogenesis; Paliperidone Palmitate | 2018 |
Asenapine at low doses as a treatment for psychotic anxiety.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Dibenzocycloheptenes; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Psychiatric Status Rating Scales; Psychotic Disorders; Treatment Outcome; Young Adult | 2016 |
Asenapine reduces anxiety-related behaviours in rat conditioned fear stress model.
Topics: Aminopyridines; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Benzodiazepines; Buspirone; Clozapine; Conditioning, Classical; Dibenzocycloheptenes; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Fear; Heterocyclic Compounds, 4 or More Rings; Hippocampus; Indoles; Male; Olanzapine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Stress, Psychological | 2016 |